Lowering Off‑Target Uptake in Biologic Radiopharmaceuticals through Protein Engineering

11:00 am - Wednesday 22nd July 2026

  • Utilizing intracellular trapping to prevent isotope and daughter escape, strengthening tumor retention
  • Providing a mechanistic basis for safer and more effective application of alpha emitters
  • Leveraging tumor-specific metabolic activity to achieve sufficient radioconjugate accumulation

Speakers:

Director - Targeting Technology Research
Telix Pharmaceuticals